President & Chief Operating Officer
Mr. Zercher was appointed as our Company’s Chief Operating Officer in June 2019 and as our President in December 2019. From 2016 to 2019, Mr. Zercher served as our Company’s Vice President of Business Development. Prior to joining 22nd Century, Mr. Zercher headed Santa Fe Natural Tobacco Company’s international business operations based in Zurich, Switzerland, where he built a thriving international business with significant sales in twelve countries. Mr. Zercher has more than twenty years of experience in the tobacco industry in marketing, sales, operations and business development in the United States, Europe and Asia.
Chief Financial Officer
Ms. Jentsch was appointed Chief Financial Officer in December 2019. From May 2019 to December 2019, Ms. Jentsch served as our Company’s Director of Accounting and Financial Reporting. Before joining 22nd Century, Ms. Jentsch had a twenty-year career at HSBC Bank USA, where she became an expert in managing assets, liabilities, and capital; cost accounting and financial system design in multi-cultural international settings, last serving as their Vice President of Financial Planning and Analysis, Governance & Policy from 2009 – 2013. From 2017 to 2019, Ms. Jentsch was Director of Finance and Administration at First Healthcare Products, Inc.
Juan Sanchez Tamburrino
Ph.D., Vice President of Research and Development
Dr. Tamburrino was appointed Vice President of Research and Development in December 2017. Following six years of post-doctoral research at the Rockefeller University in New York, Dr. Tamburrino served as an Associate Professor at Universidad Tarapacá in Chile before becoming the Research Manager at Pioneer Hi-Bred International (now known as DuPont Pioneer). In 2009, Dr. Tamburrino was appointed the head of the Plant Biotechnology Division of British American Tobacco in Cambridge, England, where he was responsible for biotechnology strategy related to tobacco leaf. Dr. Tamburrino holds a Ph.D. degree in molecular biology and genetics from the Weill Cornell Graduate School of Medical Sciences at Cornell University, a partnership program with the Sloan Kettering Cancer Research Institute, and he is a Master of Business Administration candidate at the University of Bradford in Bradford, U.K.
John T. Brodfuehrer
Vice President of Strategy
Mr. Brodfuehrer was appointed as our Vice President of Strategy in December 2019 after having served as our Chief Financial Officer from March 2013 to December 2019. From March 2011 to December 2012, Mr. Brodfuehrer served as the Chief Financial Officer of Latina Boulevard Foods, LLC, or LBF, an entity formed as the result of a merger of two long-time Western New York wholesale food distributors. Prior to his employment with LBF, Mr. Brodfuehrer was Vice-President of Retail Accounting for United Refining Company, or URC. Prior to his time at URC, Mr. Brodfuehrer served in multiple roles over a twenty-four year span with NOCO Energy Corp, a diversified distributor of energy products and related services. Mr. Brodfuehrer served as NOCO’s Chief Financial Officer, Vice-President and as a member of the Board of Directors from 2000 to 2009. Mr. Brodfuehrer earned a Bachelor of Science in Business Administration, summa cum laude, from the State University of New York at Buffalo in 1979 and became a New York State Certified Public Accountant in 1981.
John D. Pritchard
Vice President of Regulatory Science
Mr. Pritchard joined 22nd Century Group as our Vice President of Regulatory Science in April 2019. Prior to that time, Mr. Pritchard was the Head of Regulatory Science for Imperial Brands, where he led that company’s technical regulatory strategy and external scientific engagement on global product regulation. Before joining Imperial Brands, Mr. Pritchard was a Toxicologist with both the U.K. Health Protection Agency (now, Public Health England) and Charles River, a leading global contract research organization for the pharmaceutical industry. Mr. Pritchard received a Master of Science Degree in Toxicology from the University of Birmingham, England and his Bachelor of Science Degree with honors in Pharmacology from the University of Aberdeen, Scotland.